Skip to main content
. Author manuscript; available in PMC: 2018 Nov 17.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Feb 2;98(4):758–766. doi: 10.1016/j.ijrobp.2017.01.224

Table 4.

Adjusted* and unadjusted odds ratios for receipt of radiation therapy and chemoradiation therapy by age group in subgroups in which adjuvant therapy is warranted

Subgroup with pT3 or pT4 disease or pN2 or pN3 disease (n= 11,361)
Subgroup with ECE present or margin-positive disease (n = 4185)
OR for receipt of radiation therapy (95% CI) P value OR for receipt of chemoradiation therapy (95% CI) P value
Unadjusted
    Age <70 y Reference - Reference -
    Age 70–79 y 0.65 (0.59–0.71) <.0001 0.46 (0.38–0.54) <.0001
    Age ≥80 y 0.38 (0.33–0.42) <.0001 0.17 (0.13–0.24) <.0001
Adjusted*
    Age < 70 y Reference - Reference -
    Age 70–79 y 0.67 (0.61–0.75) <.0001 0.50 (0.41–0.61) <.0001
    Age ≥80 y 0.40 (0.35–0.45) <.0001 0.19 (0.14–0.27) <.0001

Abbreviations: CI = confidence interval; ECE = extracapsular extension; OR = odds ratio.

*

Adjusted for sex; race; year of diagnosis; comorbidity score; region of country; facility; oral cavity site; distance from facility; income; and urban, metropolitan, or rural residence.